The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2015
Filed:
Dec. 05, 2007
Applicants:
Allen A. Fienberg, New York, NY (US);
Sharon Mates, New York, NY (US);
Lawrence P. Wennogle, New York, NY (US);
Inventors:
Allen A. Fienberg, New York, NY (US);
Sharon Mates, New York, NY (US);
Lawrence P. Wennogle, New York, NY (US);
Assignee:
Intra-Cellular Therapies, Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/54 (2006.01); A61K 31/505 (2006.01); A01N 43/52 (2006.01); A61K 31/415 (2006.01); A01N 43/56 (2006.01); C07D 491/00 (2006.01); C07D 239/70 (2006.01); A61K 31/495 (2006.01); A61K 31/00 (2006.01); A61K 31/519 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01);
U.S. Cl.
CPC ...
A61K 31/495 (2013.01); A61K 31/00 (2013.01); A61K 31/519 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01);
Abstract
The present invention relates to a new use for compounds that inhibit phosphodiesterase 1 (PDE1), e.g., that inhibit PDE1-mediated suppression of the dopamine D1 receptor and/or progesterone signaling pathways, including, e.g., methods of treatment or prophylaxis for conditions which may be ameliorated by enhancing the progesterone signaling response, particularly female sexual dysfunction.